Amarin Corp Plc (AMRN)

[bfost]

CMM - I agree with you

I do appeals for insurers. Every appeal denial must pass through the hands of a physician - not an algorithm or a robot. (initial denials are algorithms). And every peer to peer request must be allowed. Even if the denial is upheld due to a formulary issue it will make the Pharmacy and Therapeutics committee aware of the issue and they may possibly review the decision. Contrary to popular belief the people on these committees often want to do things in the best interest of the patient as they analyze the cost/benefit issues involved.
Paying an extra $50 month for a 25% MACE reduction is different than $1000/ month for a 15% reduction (ex. PCSK9's).

It's not quick or easy but getting better coverage needs a multi pronged approach with AMRN, providers and patients while we wait for the expanded label.